Want to join the conversation?
Biotechnology company $AMGN said the European Commission (EC) has approved the marketing authorization for Kyprolis to include use in combination with dexamethasone for adults with multiple myeloma, an incurable blood cancer, who have received at least one prior therapy.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.